top of page

Accelerates

Accelerate the diagnosis of key business issues.

Expediting New Product Indication Launch for Market Growth

  • Problem solved: Leveraged patient insights to shift brand strategy, focus on patients and outpaced the category’s growth

  • Initiated a patient-centric approach that embraced the patient journey from diagnosis to medication resulting in optimized language for effective communication and engagement

  • Energized the sales team and grew the revenue to +$100M in sale and 23% growth above the category

  • Leveraged KOL support to develop a peer review article showcasing the relevance of the new product indication


Clinical Trial Success for Launch)

  • Project: Pre-Launch Engagement with Key Opinion Leaders (KOL) and Patient Communities: Conducted key informant interviews and quantitative surveys with rare autoimmune patients and healthcare specialists to gather deep insights on experiences with diagnosis, referrals, symptoms and challenges.

    • Results: Leveraged insights to develop engaging communication, patient journeys and to enable co-creation of enhanced clinical trial protocols.

bottom of page